Topics
-
Sysmex Selected as One of the Global 100's Most Sustainable Companies in the World for the Fourth Time
-
Sysmex Endorses Recommendations of the Task Force on Climate-Related Financial Disclosures (TCFD)
-
Our Response to the Coronavirus Disease 2019
-
Sysmex Awarded the "Prime" Status by ISS ESG Corporate Rating
-
Sysmex Selected for Inclusion in the Dow Jones Sustainability World Index for the Fifth Consecutive Year
-
Sysmex Presents Academic Report with a View to Creating a Simple Method of Diagnosing Alzheimer’s Disease Using Blood
Press Releases
- Sysmex Selected as One of the Global 100's Most Sustainable Companies in the World for the Fourth Time (PDF：173KB)
-
Sysmex and Roche Renew Agreement for Global Alliance
- Transforming a long-standing alliance into one for the next generation - (PDF：145KB) -
Kobe University and Sysmex Conducted Clinical Evaluation of the ELISPOT Method: A New Test for COVID-19 using blood
- Report on T cell Immunity to SARS-CoV-2 in the Japanese Population - (PDF：561KB) - Sysmex Obtains Marketing Approval for the HISCL™ IFN-λ3 Assay Kit, a Test Kit to Assist in Determining Exacerbation Risk in Novel Coronavirus (SARS-CoV-2)-Positive Patients (PDF：172KB)
- Sysmex Launches Surgical Robot Unit, hinotori™ Surgical Robot System (PDF：154KB)
